Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Seaway Pharma Inc.
483
•Seaway Pharma Inc.•July 24, 2024

FDA 483 - Seaway Pharma Inc. - July 24, 2024

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

An FDA inspection of Seaway Pharma Inc. in Massena, NY, revealed a significant issue with the physical plant's plumbing system. The observation noted a cross-connection risk between waste/sewage lines and water used for manufacturing dietary supplements, cleaning, or hand-washing facilities. This indicates a potential for insanitary conditions impacting product quality and safety.

Company
Seaway Pharma Inc.
Inspection Date
July 24, 2024
Product Type
Drugs
Office
New York District Office
Person
  • Lirissia Mccoy
Open in Dashboard

ID · c9172b7d-5459-4623-af9a-98a86d9be5fd

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.